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ABBREVIATIONS
LSV - Long saphenous vein
SFJ - Saphenofemoral Junction
ABPI - Ankle Brachial Pressure Index
HHD - Hand Held Doppler
CEAP - Clinical, Etiopathological, Anatomical, Pathology
EVLA      - Endovenous laser ablation
Hr            - Hour
IVC          - Inferior vena cava
LSV          - Long saphenous vein
RBC       - Red blood cell
RFA        - Radiofrequency ablation
SEC        - Seconds
SFJ         - Sapheno femoral junction
SPJ         - Saphenop opliteal junction
SSV        - Short saphenous vein
SYN         - Synonym
USG         - Ultrasonography
VFI            - Venous filling index
WKS          - Weeks
CVI            - Chronic venous insufficiency
DVT           - Deep vein thrombosis
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CLINICAL EXAMINATION PROFORMA
NAME   :
AGE  :
SEX :
ESI NO:
Date of examination:
? Address and contact number:
? Occupation- a)     &b)whether it involves continuous standing –
c)if yes, how many hours per day &for how long(months/years)
? Presenting complaints with duration
[Asymptomatic, Pain, Itching, Swelling of legs, Discolouration of
skin of lower limbs, Ulceration of legs, Any swelling in the
abdomen]
? Personal history: in women previous obstetric history (any H/o of
swelling of legs during previous pregnancy) any h/o oral
contraceptive pills usage .H/o smoking/Alcohol intake
? Family history – Similar Illness in: any members of the family.
CLINICAL EXAMINATION
           INSPECTION :
 1. varicose veins (LSS or SSS)
 2.swelling-localised or generalised
? Skin over the limb
colour, texture,edema,eczema,pigmentation & ulceration (size, site
surface, scar)
? Signs of ischemia (cold clammy skin, loss of hair, thinning skin,
brittle nails, marked pallor, purple blue cyanosed, ulceration of
digits, wasting of muscles)
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 PALPATION:
? Temperature
? Tenderness
? Brodie Trendelenberg test 1& 2
? Multiple Tourniquet test
? Perthes test
? Modified Perthes test
? Schwartz test
? Pratt’s test
? Morrissey’s test
? Fegan’s test
? Percussion
? Auscultation
? Other Systems examination
VCSS   QUESTIONNAIRE
1) DO YOU HAVE PAIN
IN THE LEGS ?
IF YES, WHERE DO YOU BELONG IN THE FOLLOWING
CATEGORY?
1A)Occasional ,not
restricting  activity
1 a)no analgesics
Y N
Y N
2B)Daily, not able to
perform occupational
activities
2b)occasional
analgesics(<3/7
 days/week)
Y N
Y N
Y N R L
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3C)Not able to perform
day to day activity  daily
3c)Regular use of
analgesics(7/7days in a
week )
Y N
Y N
2)ANY  DILATED VEINS IN THE
LEGS?
IF YES, WHERE DOES THIS PATIENT BELONG IN THE
FOLLOWINGCATEGORY ?
Few, isolated varices Y N
Multiple (LSV) or (SSV)
calf varices only
Y N
Extensive (LSV,SSV)
varices of calf and
 Thigh
Y N
3)ANY SWELLING OF THE LEGS?
3a) IF YES WHEN ?
3 i)Evening only Y N
3ii)Evening &After
noon
Y N
3iii)Whole day
3 b) WHERE?
3i)at ankle
Y N R L
Score
Y N R L
Y N
score
Y N
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3ii)above the ankle(Lower 1/3rd of ankle)
3iii)above the ankle(upper 1/3rd ofankle
requires activity change & elevation
4) ANY SKIN CHANGES IN THE
LEGS
IF YES WHAT KIND OF ??
4A) DISCOLOURATION OF SKIN
i)DIFFUSE LIMITED
ii) DIFFUSE LOWER 1\3RD
iii)WIDER UPPER 1\3RD
4B )CELLULITIS OF LEG
I)AROUND  THE  ULCER
II)LOWER1\3RD LEG
III) UPPER 1\3RD LEG WITH
DISCHARGE
4 C )  INDURATION OF LEGS
I)ONE SIDE(MEDIAL OR LATERAL
SIDE) OF  ANKLE
II)BOTH SIDES OF ANKLE
III)ENTIRE LOWER 1\3RD LEG
Y N
Y N
Y N R L
Y N
Y N
y N
Y N
Y NScore
y N
Y N
Y N
Y N
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5)ANY LEG ULCERS?
IF YES
5 A) NUMBER OF LEG ULCERS ?
i)1
ii)2
iii)>2
5B )DURATION OF LEG ULCERS
I)< 3months
II)3 months- 1 yr
III)>1 yr
5 C ) SIZE OF LEG ULCERS
I)< 2cms
II)2cms -6cms
III)>6cms
                 VDS QUESTIONNAIRE
1) DO YOU FEEL ANY PAIN OR HEAVINESS IN YOUR LIMBS?
YES            NO            RIGHT            LEFT
2) IF YES, ARE YOU ABLE TO CARRY OUT YOUR WORK
NORMALLY AS BEFORE?  YES               NO
3) ARE YOU ABLE TO CARRY OUT YOUR WORK  WITH  OR
WITH OUT CREPE BANDAGE ?  YES           NO
R L Y N
Y N
Y N
Y N
Y N
Y N score
Y N
Y N
Y N
Y N
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SCORE :
a) VENOUS CLINICAL SEVERITY SCORE (VCSS)  - out of 30
b) VENOUS DISABILITY SCORE(VDS) - out of 3
TOTAL SCORE-
CATEGORY OF THE PATIENT ACCORDING TO VCSSVENOUS
REFLUX GRADING
1) Mild ( 0-10)-
1) Mild reflux
2) Moderate (11-20)-(VS)
2) Moderate reflux
3) Severe (21-30)-
3) Severe reflux
CATEGORY OF THE PATIENT ACCORDING TO VDSVENOUS
REFLUX GRADING
0 / 1 / 2 / 3 (VS)
1) Mild reflux 2) Moderate reflux
3) Severe reflux
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INFORMATION SHEET AND CONSENT FORM
Informed consent for patient who are attending surgical OPD in
ESI-PGIMSR hospital, and whom we are inviting to participate in
research titled "A CORRELATIVE  STUDY OF VENOUS CLINICAL
SEVERITY SCORE (VCSS), VENOUS DISABILITY SCORE (VDS)
AND VENOUS REFLUX GRADING BY VENOUS DOPPLER IN
VARICOSE VEINS OF LOWER LIMBS AT ESI-PGIMSR, KK Nagar,
Chennai, 2012-13". Dr.R.ALAGARSAMY, M.S. (General surgery) post
graduate is the principal investigator of this research under ESI-PGIMSR,
Chennai.
INTRODUCTION
We, Dr.R.ALAGAR SAMY, IIIYr, GeneralSurgery pgGuidedby
Dr.R.ANBAZHAKAN , MS,FAIS
Professor & HOD Of Surgery& Dr. UDAY SHAMRAO
KUMBHAR ,MS, Associate Professor Of Surgery, are going to give you
information and invite you to be part of this research. Before you decide,
you can talk to anyone of us you feel comfortable with about the research.
This consent form may contain words that you do not understand. Please
ask us to stop as we go through the information and we will take time to
explain. If you have questions later, you can ask us.
Purpose of the research
We will be studying whether there is correlation between clinical severity
score (VCSS), venous disability score (VDS) and venous reflux grading
(VRS)by venous Doppler in varicose veins of lower limbs
Cl
ick
 he
re 
to 
bu
y
A
BB
YY
PDF
Transformer 2.0
www.ABBYY.c
om
Cl
ick
 he
re 
to 
bu
y
A
BB
YY
PDF
Transformer 2.0
www.ABBYY.c
om
Type of Research
This research will involve your participation in an observational manner,
with assured privacy and confidentiality.
Right to Refuse or Withdraw
Your participation is strictly voluntary. Refusal to participate will not
affect subsequent services to you
Procedures
If you give consent to participate in this study, we will ask you questions
regarding your illness. A history will be taken recording symptoms,
duration of disease, occupation. The degree of disability is assessed by
questionnaire. The site of varicose vein, system of involvement (LSV or
SSV or Perforator incompetence), any complications will be assessed by
clinical examination.Abdominal and pelvic examination will be done to
rule out abdominal tumors, other causes of raised intra abdominal tension
.Cardio vascular system & peripheral arterial pulses will be carefully
examined to exclude arterial disease associated with varicose vein. Then
you will undergo standard colour Doppler ultra sonogram to find out
system  of  involvement  [LSV  or  SSV]  and  to  rule  out  DVT.  If  LSV  is
involved further grading of venous reflux at sapheno-femoral junction of
involved limb will be done.
By using colour Doppler, sapheno-popliteal junction & deep venous
system will be assessed. In  Doppler studies, you will be examined in
1. In standing position only  2. During the valsalva maneuver.
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Valsalva maneuver: (to test the competency of proximal deep veins, SFJ).
Reflux is elicited at above sites during this maneuver in the standing
positions.
3.Augmentation of venous return of lower limbs by calf compression in
prone position .
Confidentiality will be maintained throughout the study.
Risks
This study is purely beneficial to you with no expected risks
Benefits
Your participation will help us improve the management of varicose
veins of lower limbs .A positive correlation between venous severity
scores and venous reflux by  Doppler examination &Reduction in Venous
severity score post- operatively is a reliable indicator of the effectiveness
of  surgery
Possible long term outcome – The scoring system may assist us  in
determining   the type of management.You will not be provided any
incentive or travelling allowances to take part in the research.
Confidentiality
All information you provide will be kept confidential. Your name will not
be used in any way.
Whom to Contact
If you have any questions, you can ask them now or later. If you wish to
ask questions later, you may contact:,Dr.R.Alagar Samy, IIIYr, General
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Surgery pg ph no: 9790435880,department of general surgery , ESI-
PGMSR , K.K.NAGAR Chennai- 78.
This proposal has been reviewed and approved by Institute Ethics
Committee, which is a committee whose task it is to make sure that
research participants are protected from harm.
If you have any questions regarding any part of the study, feel free to ask.
CONSENT FORM
I have read the information in the consent form (or it has been read
to  me.)  I  was  free  to  ask  any  questions  and  they  have  been  answered.  I
understand what is being requested of me as a participant in this study.  I
have been given satisfactory answers to my questions.  I certify that I am
more than 18 years of age. I freely consent to participate in the study
called “A CORRELATIVE  STUDY OF VENOUS CLINICAL
SEVERITY SCORE (VCSS), VENOUS DISABILITY SCORE (VDS)
AND VENOUS REFLUX GRADING BY VENOUS DOPPLER IN
VARICOSE VEINS OF LOWER LIMBS AT ESI-PGIMSR, KK Nagar,
Chennai, 2012-13".
I have read and understood this consent form and the information
provided to me. I have been explained about the nature of the study. My
rights and responsibilities have been explained by the investigator I agree
to cooperate with the investigator. Currently I am not participating in any
research study. I hereby give permission to the investigators to release the
information obtained from me as a result  of  participation in the study to
the regulatory authorities, government agency, ethics committee. I
understand that they may inspect my original records.
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My records will be kept confidential I have decided to participate
in the study. As I was not able to read, the consent form has been read out
to me by the investigator and all my questions have been answered and i
give my consent with my free will.
______________________________________
Name of Participant
______________________________________    ______________
Sign of Participant Date
______________________________________    ______________
Name of Investigator  (Signed)                                   Date
Cl
ick
 he
re 
to 
bu
y
A
BB
YY
PDF
Transformer 2.0
www.ABBYY.c
om
Cl
ick
 he
re 
to 
bu
y
A
BB
YY
PDF
Transformer 2.0
www.ABBYY.c
om
Cl
ick
 he
re 
to 
bu
y
A
BB
YY
PDF
Transformer 2.0
www.ABBYY.c
om
Cl
ick
 he
re 
to 
bu
y
A
BB
YY
PDF
Transformer 2.0
www.ABBYY.c
om
Cl
ick
 he
re 
to 
bu
y
A
BB
YY
PDF
Transformer 2.0
www.ABBYY.c
om
Cl
ick
 he
re 
to 
bu
y
A
BB
YY
PDF
Transformer 2.0
www.ABBYY.c
om
Cl
ick
 he
re 
to 
bu
y
A
BB
YY
PDF
Transformer 2.0
www.ABBYY.c
om
Cl
ick
 he
re 
to 
bu
y
A
BB
YY
PDF
Transformer 2.0
www.ABBYY.c
om
ABSTRACT
The study on  correlation  between VENOUS CLINICAL SEVERITY
SCORE (VCSS), VENOUS DISABILITY SCORE (VDS) AND
VENOUS REFLUX GRADING BY VENOUS DOPPLER in Varicose
veins of lower limbs
Abstract: The study was aimed at studying the correlation between
VENOUS CLINICAL SEVERITY SCORE (VCSS), VENOUS DISABILITY
SCORE (VDS) AND VENOUS REFLUX GRADING BY VENOUS DOPPLER
in Varicose veins of lower limbs.This study was conducted in the
Department  of  General  surgery,  ESI-PGIMSR,  over  a  period  of
18months. The study group consisted of 75 patients between 24 to 75yrs
(mean 44.41 ± 12.967), inclusive of both males(n=70) and females(n=5).
They were assessed for severity of varicose veins by documenting a
detailed history, clinical examination findings and imaging studies on a
pre structured  proforma.
It was found that majority of the patients were ? 60yrs and the right
lower limb was predominantly affected in both sexes. Using the VCSS
system, 66.7%(n=50) cases had mild disease, 33.3%(n=25) cases had
moderate disease and none had severe disease.
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In the present  study, as per the VDS system, majority of the
patients(n=71, 94.7%) had grade II disability. And 76%(n=57) of the
patients had severe grade of venous reflux i.e. venous reflux duration
>1second.A statistically significant correlation was found between
clinical manifestations of varicose veins and the degree of reflux in the
veins, assessed using the VCSS and VRS system, respectively.
Key words: VCSS, VDS, VRS , proforma, venous reflux
Ref: Venous Clinical Severity Score and quality-of-life
assessment tools: application to vein practice.  M A Vasquez,  C E
Munschauer ; Phlebology. 2008 ;23 (6):259-75
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1INTRODUCTION
Varicose veins of  the lower limbs is a common clinical condition1
that  we  encounter  in  the  surgical  clinics  of  our  hospital  –  the  ESIC
Medical college and PGIMSR [statistics follows].The term varicose is
derived from the latin word “varix” meaning bent and refers to dilated,
tortuous & lengthened veins of lower limbs2. Varicose veins of lower
limb occur due to loss of valvular efficiency3 which  is  a  product  of  the
resultant venous hypertension in standing position. Most commonly
occurs in females3 compared to males according to western studies. In
contrast to western studies, males are more affected than females in our
hospital as per statistics.
INCIDENCE OF VARICOSE VEINS AT ESICM & PGIMSR,
CHENNAI - 2011.
Total number of varicose veins   in the outpatients:
431 (Male-388, Female - 43)
Total   number of varicose veins in the inpatients :
110   (Male-103, Female-7)
Total   number of varicose ulcer in the OP&I  :
45 (Male-42, Female-3)
Total number of patients underwent surgery :
65 (Male-61, Female-4)
(Trendelenberg ligation & stripping)
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2The anatomy of the arterial system is relatively constant 4 but that
of venous system is subject to individual variation. In the lower limb
superficial veins carry only about 10% 6of blood where as remaining
passes via deep veins. Superficial veins lie superficial to muscle and
fascia of the limb5. All veins contain valves every few centimetre, which
ensures that blood flows towards the heart.
THE VENOUS SYSTEM:5
For practical purpose the veins may be divided into 3 main
systems.
a. The superficial system
b. The perforator system
c. The deep system
The superficial veins are found under the skin in the subcutaneous
tissue. The deep venous system accompanies the arteries. Valves are
present in both systems, but are more numerous in the deep veins.
The superficial system
The superficial system of the leg consists of two major veins and
their tributaries, namely the long and short saphenous veins. They lie
superficial to deep fascia.
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3FIGURE - 1
Superficial veins and Perforating veins of the lower limb
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4FIGURE – 2
Deep veins of lower limb
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5PHYSIOLOGY OF THE VEINS OF LOWER LIMB
As might be expected the leg veins are thicker walled7 and possess
a greater development of adventitial connective tissue8 than elsewhere.
Such structural  modifications seem to be related to the gravitational
stresses which these leg  veins have to endure.
1. The superficial veins have smooth muscle in their walls and the
deep veins do  not have making them more or less passive reservoir
of blood7. Whereas  superficial veins contract in response to direct
stimuli and other stimulus like  cold, warm, and drugs.
2. The physiology of venous return from the leg is quite different
when lying  prone and when standing up. By the time it emerges
from the capillaries it is at low pressure  (about 20mmHg)9, but this
is enough for the blood to return to the heart.
Following factors help in venous return9
1. Negative pressure in the thorax.
2. The calf muscle pump.
3. Vis - a –tergo
4. Competent valves.
Cl
ick
 he
re 
to 
bu
y
A
BB
YY
PDF
Transformer 2.0
www.ABBYY.c
om
Cl
ick
 he
re 
to 
bu
y
A
BB
YY
PDF
Transformer 2.0
www.ABBYY.c
om
6PATHOLOGY OF VARICOSE VEINS11
It typically consists of a retrograde circuit having 4 components.
1. A source of out flow from deep to superficial veins at high
level.
2. A pathway of incompetence running down the limb.
3. Re-entry points where superficial down flow joins the deep
veins.
4. A return pathway provided by the deep veins and the
musculo venous pumping mechanisms.
Venous reflux9 appears to be most important factor in majority of
CVI (chronic venous insufficiency) patients. These changes are vital in
the “gaiter areas”9 around the ankles due to sparse soft  tissue support  to
withstand elevated venous pressures and common site for affected
perforator veins.
 The most common abnormality in patients with CVI is
incompetence of the  popliteal or tibial veins5; 50-60%9 of patients have
incompetent perforators.
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7The most frequent complaints for which patient seeks help are :
1. Disfigurement9: (Prominent veins in the limb) those who
present with thiscomplaint have a variety of symptoms
ranging from gross unsightly multiple varicosities to an
engorged small tributary. These dilated veins may or may
not be associated with complications.
2. Pain in the limb9: The commonest presenting complaint in
our country seems to be ache or pain in the lower limb
increasing  as  the  time  goes  on.  The  pain  is  aggravated  by
prolonged standing and exercise, relived while lying down .
Complications9:
Patient may present with the following complications of the
disease.
a) Haemorrhage
b) Thrombophlebitis
c) Eczema and Dermatitis
d) Other uncommon complications like
? Calcification of the vein
? Periosteitis.
Cl
ick
 he
re 
to 
bu
y
A
BB
YY
PDF
Transformer 2.0
www.ABBYY.c
om
Cl
ick
 he
re 
to 
bu
y
A
BB
YY
PDF
Transformer 2.0
www.ABBYY.c
om
8? Equinus deformity
? Saphena varix.
? Atrophie Blanche.
? Lipodermatosclerosis.
? Corona phlebectatica.
CLASSIFICATION OF CHRONIC VENOUS DISEASE (C,E,A,P)9
Clinical classification9
C0  – No visible or palpable signs of venous disease
C1  - Telangiectasies or reticular veins.
C2   - Varicose veins; distinguished from reticular veins by a
diameter of 3 mm or more.
C3  - Edema
C4   - Changes in skin and subcutaneous tissue.
C4  a)  - Pigmentation or eczema.
C4 b) - Lipodermatosclerosis or atrophie blanche.
C5  - Healed venous ulcer.
C6   - Active venous ulcer.
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9Etiologic Classification9
Congenital (EC) Cause of the chronic venous disease present since
birth Primary (EP) Chronic venous disease of undetermined cause
Secondary (ES) Chronic venous disease with an associated known cause.
Anatomic Classification (AS, AD, or AP)9
The anatomic site(s) of the venous disease should be described as
superficial (AS), deep (AD), or perforating (AP) vein(s).
Patho physiologic Classification9
Reflux (PR)
Obstruction (PO)
Reflux and obstruction (PR, O)
VENOUS CLINICAL SEVERITY
SCORE(VCSS)
Attribute Absent=0 Mild 1 Moderate 2 Severe 3
Pain None Occasional
,not
restricting
activity, no
analgesics
Daily,moder
ate activity
limitation
occasional
analgesics
Severe Limitation
of activity
daily,regular use
of analgesics
Varicose veins None Few,
isolated
varices
Multiple
(LSV) or
(SSV) calf
varices only
Extensive
(LSV,SSV)
varices of calf and
thigh
Venous edema None Evening
only at
ankle
Evening
&After
noon above
the ankle
Whole day above
the ankle ,requires
activity change &
elevation
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10
VCSS
Pigmentation of
skin
None Diffuse,
limited area
old pigment
(brown)
Diffuse most of
the gaiter
region, lower
1/3 of leg recent
pigment
(purple)
Wider upper 1\3
of leg, recent
pigment (purple)
Inflammation None Cellulitis mild
around ulcer
margin
Cellulitis
Moderate in
gaiter region,
lower 3rd of
leg
Cellulitis
Severe above the
lower 3rd of leg
or eczema
Induration None Focal <
5cm,circumall
eolar region
Medial or
lateral, <1/3 of
leg
Entire lower
1/3rd of leg
No of active ulcer
Size of active ulcer
0
0
1
Less than 2 cm
2
2-6cms
More than 2
More than 6cms
Duration of active
ulcer
None < 3M 3m to 1 year More than 1year
Compressive therapy None Occasional use Intermittent
use
Regularly use
VENOUS DISABILITY SCORE(VDS)
SCORE DEFINITION
• 0  Asymptomatic
• 1  Symptomatic, but able to carry out usual activities*
with-out   compressive therapy
• 2  Able to carry out usual activities* only with
compressive therapy and/or  limb elevation
• 3  Unable to carry out usual activities* even with
compressive therapy  and/or limb elevation
{Usual activities = patients all activities before the onset
of disability due to venous disease}
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11
Grading of venous reflux (VRS)
By noninvasive colour doppler imaging
Grade Reflux duration
Mild  reflux            GRADE 1 Reflux duration of <0.5
sec,rapid closure of venous
valves
Moderate reflux     GRADE 2 Reflux duration of  0.5 -1sec
mild to moderate retrograde
flow
Significant reflux    GRADE 3 Reflux duration of >1sec ,large
volume of retrograde flow
NORMAL VALVE FUNCTION No reflux,rapid closure of venous valves
31
METHOD OF DOPPLER EXAMINATION AND SONOGRAPHIC
ANATOMY14-18
The choice of transducer for evaluating the lower extremity veins
depends on the patient’s body habitus and the depth of the vessel to be
studied. The examination is preferentially performed with a high-
resolution 5- to 7.5-MHz 14linear array transducer.
For very superficial veins (ie, the greater or small saphenous
veins), a 10-MHz transducer may be optimal. For large patients a lower-
frequency14 (2.5- or 3.5-MHz) curvilinear transducer may be necessary.
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12
Briefly, the great saphenous vein (GSV) joins the common femoral
vein (CFV)15 just superior to its bifurcation. It travels medially in the
thigh and calf extending inferiorly to the level of the foot. It measures
about 3 to 515 mm in diameter at the level of the saphenofemoral junction,
tapering to about 1 to 3 mm in diameterat the level of the ankle.
Measurement of the GSV is important before harvesting for autologous
vein grafting. The small saphenous vein (SSV) (formerly called the
‘‘lesser saphenous vein’’) extends from the ankle along the posterior
aspect of the calf to insert at variable levels into the posterior proximal or
mid popliteal vein (PV). The diameter of the SSV tapers from 2 to 4 mm
proximally to about 1 to 2 mm distally. Both the GSV and SSV may
become enlarged and varicose in patients who have venous insufficiency
or congestive heart failure. Thrombosis of these vessels may occur with
ensuing superficial thrombophlebitis.
The deep venous system16 includes  the  CFV,  the  deep  femoral  or
profunda femoris vein, the femoral vein (FV) (previously called the
‘‘superficial femoral vein’’), and the PV as well as the paired anterior and
posterior tibial veins and the peroneal veins. The CFV is the continuation
of the external iliac vein and extends from the level of the inguinal
ligament to the level of the bifurcation into the FV and profunda  femoris
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13
vein. The  profunda  femoris vein lies medial to the accompanying artery
and can be evaluated only in its most proximal portion.
The CFV lies medial to the accompanying artery. The FV travels
medial to the femoral artery through the adductor canal in the distal thigh.
To avoid confusion among clinicians, the term ‘‘femoral vein’’ (FV)
should be used instead of the previously designated term ‘‘superficial
femoral  vein’’  to describe that  part  of  the deep venous system caudal  to
the bifurcation of the CFV. (In a survey performed by Bundens and
colleagues, more than 70% 17of surveyed internists regarded the
‘‘superficial femoral vein’’ as part of the superficial and not the deep
venous system and thus were under the assumption that superficial
femoral  vein  thrombosis  did  not  require  treatment.)  The  PV  is  the
continuation of the FV after its exit from the adductor canal in the
posterior distal thigh. The PV is located anterior to its accompanying
artery and courses through the popliteal space into the proximal calf.
In addition, the muscles of the calf are drained by gastrocnemius
and soleus veins18, which do not have accompanying arteries. A complete
examination includes evaluation of the full length of the CFV and
saphenofemoral junction, the proximal portion of the deep femoral vein,
the FV, and the PV.
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In obese patients compression in the adductor canal may be
difficult. Sometimes a two-hand technique, pushing the leg into the
transducer with the free hand from behind, may help achieve adequate
compression17.
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DOPPLER EXAMINATION IN A STANDING POSITION
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DOPPLER IMAGING OF LOWER LIMB VEINS
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17
Method of examination17
Designing a treatment plan for a patient who has varicose veins
requires identification of the highest as well as the lowest point of reflux.
In addition, the source of reflux must be identified for every varicosity.
This identification is accomplished by a combination of visual inspection
and Doppler USG. Because the examination can be time consuming, it
may be helpful to have a walker, table, or counter to help support the
patient as well as a stool for the examiner. Either colour or pulse Doppler
can be used, and three different methods can be attempted to elicit reflux:
1. Augmentation17: The leg is squeezed from below, directing
flow toward the heart. If blood flows back toward the feet for more than
half seconds Following augmentation, the examination is positive for
reflux, although some examiners require a full second of reflux before
considering the examination to be positive. Transient retrograde flow is
normal and serves to push back the valve leaflets, causing them to close.
2. Valsalva maneuver17: Reflux can be assessed in the thigh after
the Valsalva maneuver because the resultant increased intra-abdominal
pressure causes retrograde flow through incompetent valves. Although
this technique is sensitive, it works well only in the upper thigh. If the
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terminal and/or subterminal valves in the GSV are competent, the
Valsalva maneuver will not detect more distal points of reflux.
3. Direct or retrograde compression17: Direct compression above
the point of Doppler interrogation propels blood toward the feet in the
setting of an incompetent valve. Although it is easiest to assess for reflux
in the longitudinal plane using colour Doppler or pulse Doppler
interrogation, with experience the examination can be performed more
efficiently in the transverse plane with colour Doppler while angling the
transducer toward the head or feet.
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AIM OF THE STUDY
To find out the correlation between   the venous clinical severity
score, venous disability score with the grading of venous reflux by
venous Doppler in varicose veins of lower limbs.
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MATERIALS AND METHODS
After  consulting  with  the  statistician  the   sample   size  set  was  75
Patients  in the study as per the following  calculation.
SAMPLE SIZE = 2PQ (Z?+Z?)2
                                         -----------------------
     (P1-P2)2
P = P1+P2\2                Q = 100 - P
 Z?= 1.96                      Z?= 0.84
P1 = 100%                    P2 = 90%
SAMPLE SIZE = 75
INCLUSION CRITERIA
Patients who were attended surgical OPD with primary varicose
veins diagnosed by history , clinical examination and imaging techniques.
EXCLUSION CRITERIA
• Pregnancy
• Intra abdominal tumors / Pelvic tumors
• Deep vein thrombosis
• Varicose vein with Peripheral  arterial  disease of lower limbs
• Isolated perforator incompetence
• Recurrent varicose veins after previous surgery(REVAS)
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METHODS
Both  Venous  clinical  severity  score  [VCSS]9 &Venous disability
score [VDS]9 were evaluated by Questionnaire and Clinical examination.
The  Noninvasive standard  color Doppler examination16 had performed
for assessing the following parameters.
i) Grading of venous reflux at SFJ
ii) Competency of SPJ
iii) Patency and competency of deep venous system of lower
limb.
In  this study   conducted  at  ESIC Medical college and  PGIMSR,
K.K. Nagar, Chennai for the period  of  one  year and six months. After
obtained  informed consent, a total of 75 patients with primary varicose
veins,  from those who   attended  the surgical  OP,  were  included.  The
history  was  taken  recording  symptoms,  duration  of  disease  and
occupation.
The degree of disability was assessed by questionnaire. The site of
varicose veins, system involved (LSV or SSV or Perforator
incompetence) and if  any  associated  complications were  assessed by
clinical examination.
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Abdominal and pelvic examination were  done to rule out
abdominal tumors and  other causes of raised intra abdominal pressure
.Cardio vascular system and  peripheral arterial pulses  were carefully
examined to exclude arterial disease associated with varicose vein.
The patients underwent standard color Doppler ultra sonogram to
find  out  system  of  involvement  [LSV  or  SSV].  In  patients  with  LSV
involvement further grading of venous reflux at sapheno-femoral junction
was assessed. By using color Doppler, sapheno-popliteal junction and
deep venous system were assessed for reflux and thrombosis respectively.
In Doppler studies, the patients were examined
A) In standing position
B) During the valsalva maneuver.
Valsalva  maneuver17: (to  test  the  competency  of  proximal  deep
veins,  SFJ). Reflux was elicited at above sites during this maneuver in
the standing position.
C) Augmentation17 of venous return of lower limbs by calf
compression in prone position was done. Augmentation by Calf
compression : (for evaluating the venous competency). A  gentle calf
squeeze    at  the proximal veins of lower limb and the Foot squeeze at the
level of  calf veins of lower limb  were done by means of   Pneumatic calf
cuff inflation and deflation. Then calf compression was abruptly removed
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and looked for any  backflow of blood from venous valves and if so  the
duration of venous reflux was noted.
In  color  Doppler examination, 5MHz  and  10 MHz probe15 were
used for Quantifying the flow and obtaining hemodynamic information
.Both were observed at rest, during valsalva maneuver and augmentation
by calf compression.
In patients with venous incompetence during valsalva maneuver
and augmentation, abnormal reflux15 towards probe (red) at SFJ was seen.
The reflux at the SPJ in the popliteal fossa and the patency of deep
venous system were also assessed in prone or sitting position.
After history and clinical examination and color Doppler
examination  patients were  categorized  into three groups .The three
groups were divided as mild ,moderate and severe according to the scores
0-9, 10-20, 21-30 respectively. After categorization correlation was done
by Pearson method.
The venous refluxes 18 are of three types. They are grade I, grade
II, and grade III according to the duration elicited by venous Doppler
examination. Normally venous reflux is absent at SFJ.  Presence of reflux
is considered as abnormal. The duration of reflux was measured and
graded as follows. The grade I –up to 0.5 second.  Grade II – 0.5 to 1
second, Grade III – more than 1 second.
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THE  CORRELATION OF CLINICAL SCORING (VCSS, VDS)
versus  VRS BY DOPPLER IMAGING
?
Vs
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CORRELATION OF CLINICAL SCORING (VCSS, VDS) with
VRS (venous reflux scoring)
Clinically all 75  patients were  classified as mild, moderate and
severe  category according to venous clinical severity score (VCSS) to
correlate with VRS.
a) Mild (0-9)
b) Moderate (10-20)  Vs  Venous reflux score (Grade1/2/3)
c) Severe (21 - 30)
Further all the patients were classified according to venous
disability score (VDS) into mild, moderate and severe category for
correlation with VRS.
a) Mild (1)
b) Moderate (2)  Vs Venous reflux score (Grade 1/2/3)
c) Severe (3)
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REVIEW OF LITERATURE
Varicose veins9 are generally identified by their abnormal, dilated,
tortuous course on the lower limbs. Varicose veins are a common
problem19; with widely varying estimates of prevalence .In general, they
are found in 10 to 209 percent of men and 25 to 339 percent of women.
Chronic venous disease in the lower extremities has a substantial effect
on  quality of life21.
Varicose veins  is a common condition affecting the middle aged
working people. A scoring system in  existence  [CEAP]9, is  used in very
few centres only.
CEAP CLASSIFICATION9
- Clinical severity
- Etiology or cause
- Anatomy
- Pathophysiology
In the CEAP9 [Clinical, Aetiological, Anatomical, Pathological]
scoring system the ‘C’ has been found to be deficient in many respects,
so  further  scores  –  the VCSS (Venous Clinical Severity Score)9 and
VDS (Venous Disability Score)9 have been developed and validated as
being more accurate, informative and easy to use. There are very few
studies to correlate the scores individually with the severity of venous
reflux by Doppler.
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This study was aimed to correlate VCSS (venous clinical severity
score) and VDS(venous disability score)  individually  with grading of
venous reflux using the standard colour Doppler in lower limb varicose
veins.
In   2000    Havoc   et  al.23 Studied the relationship between lower
limb venous symptoms  with  the  venous  reflux by duplex ultrasound
and  concluded   that the presence of  venous reflux on duplex ultrasound
scanning has relationship with  few symptoms of  lower extremity venous
disease.
Passman  et al.24 found global application of VCSS in measuring
the varicose vein related risk and changes with the treatment. Along with
VCSS, he applied CEAP and CVIQ (chronic venous insufficiency
affecting the quality of life).
Vasquez et al.27 done a study to assess  the quality of life changes
in varicose vein treatment by venous clinical severity score and found to
be  useful to measure the changes in the varicose  vein treatment.
Volksmann et al28 studied the change of the venous reflux scoring
after varicose vein surgery by duplex  ultrasound scan and concluded that
the VRS had significantly altered after varicose vein treatment especially
after surgery.
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Stavros et al31  validated  the three components in the new scoring
system i.e  VCSS,  VDS and  VSDS which   had  a   good  correlation  with
anatomic extent of the lower limb venous disease. He advised the new
scoring systems to be  included in clinical examination for  measuring
the outcome of  the varicose vein surgery.
Wang  J  et  al.32 done  a  study  at   New York   as  to   how well  the
VCSS is helpful to assess the efficacy of varicose vein treatment by
radiofrequency wave ablation and  concluded that   VCSS  was a  single
scoring system  helpful in assessing the efficacy  and  reasons for failure
of treatment.
In 2011 Smith et al.33 and many authors studied  the usefulness of
the duplex ultrasound scanning in varicose vein assessment and
concluded that duplex scan was the single effective tool for assessing the
various parameters in varicose vein.
 Edinburgh vein study34 from Scotland by vascular surgery
department in 2002 showed a strong correlation between  lower limb
clinical features and  venous reflux by Doppler ultrasound scanning.
Jessent V  et  al.35  studied   the clinical usefulness of VSS scoring
system and concluded  that  VCSS and  VDS  components of  VSS were
useful tool in clinical practice  but VSDS was not much useful in varicose
vein assessment.
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Nicholls et al.36 studied to identify the usefulness of VCSS system
in varicose vein risk assessment and to evaluate the changes after
varicose vein treatment. The study  concluded that  VCSS was  useful in
the above measurement.
In  2006  Miami  et  al.37 done a study to compare the parameters
between VCSS and CEAP in varicose vein management and  concluded
that the VCSS was a very good system in diagnosis and follow up of
chronic venous insufficiency of lower limbs.
Padberg et al.38  in 2000 done a study at USA to find out which one
was better in varicose vein  clinical features assessment  and  measure the
changes after treatment for varicose vein among CEAP and VCSS and
found  VCSS  would  be  the  ideal  tool  to  measure  the  outcome  and  risk
assessment in varicose vein  compared to CEAP which already existed
for many years.
So far no studies have done to find out how well individual
components of the  scoring system correlating with the venous reflux by
color Doppler examination method. Present study was undertaken   to
correlate VCSS (venous clinical severity score) and VDS (venous
disability score) individually  with grading of VRS (venous reflux  score)
by  using the standard colour Doppler in lower limb varicose veins.
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STATISTICAL ANALYSIS
The results were analysed using SPSS (statistical package for the
social sciences) Version 17 software with the help of the statistician. The
students paired t-test was used to correlate between two scoring system
with venous reflux. Categorical variables were analysed using Chi Square
test . Values that were not normally distributed or when the mean value
was less than two times the standard deviation, were analysed with
nonparametric statistical methods. p value <.05 was considered as
statistically significant.
GENERAL CHARACTERSTICS OF THE POPULATION
In the present study of  75 patients youngest  was  24   and eldest
was 75 years (mean  44.01) ± 12.967.  Among the 75 patients 34 were
below  40 years and remaining 34 were between 40 - 60 years.
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AGE DISTRIBUTION
TABLE - 5.1.1
Age Category Frequency Percentage
Up to 40 Years 34 45.3 %
41 – 60 Years 34 45.3 %
> 60 Years 7 9.4 %
TOTAL 75 100 %
*FREQUENCY means number patients
FIGURE - 5.1.1
Showing Age Group Distribution of the Study Population
34 34
7
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GENDER DISTRIBUTION
TABLE  - 5.1.2
Gender Frequency Percentage
MALE 70 93.3 %
FEMALE 5 6.7 %
TOTAL 75 100 %
*FREQUENCY means number patients
Among  75 patients 70 were males and 5  females. M:F ratio :14:1
FIGURE -  5.1.2
Showing Gender Distribution of the Study Population
70(93%)
5(7%)
GENDER DISTRIBUTION
MALE
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GENDER AND AGE GROUP DISTRIBUTION
TABLE - 5.1.3
Age category Male Female Total
UP TO 40 YRS 32 (45.7%) 2 (40.0%) 34 (45.4%)
41 - 60 YRS 31 (44.3%) 3 (60.0%) 34 (45.4%)
> 60 YRS 7 (10.0%) 0 (0.0%) 7 (9.3%)
TOTAL 70 (100%) 5 (100%) 75 (100%)
The maximum people were below 60 years of age. 10% males were
above  60 years.
FIGURE -  5.1.3
Showing Age Group and Gender Distribution of the Study
Population
32
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SIDE
TABLE - 5.2.1
Side Frequency Percentage
Right Side 40 53.3 %
Left Side 35 46.7 %
Total 75 100 %
*FREQUENCY means number patients
Among 75 patients 53.3% patients were presented with right sided
where as 46.7%  with left sided varicose veins.
FIGURE - 5.2.1
Showing the Side of the Reflux presentation
40(53%)
35(47%)
SIDE OF REFLUX
Right Side
Left Side
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5.2: VENOUS CLINICAL SEVERITY SCORE – PARAMETERS
TABLES AND CHARTS
PAIN
TABLE - 5.2.1
Pain score Frequency (No. Ofpatients) Percentage
Nil 0 0.0 %
1 30 40.0 %
2 43 57.3 %
3 2 2.7 %
Total 75 100 %
FIGURE - 5.3.1
Showing Pain Scores Distribution
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VARICOSITY
TABLE - 5.2.2
Varicosity score Frequency Percentage
Nil 0 0.0 %
1 3 4.0 %
2 71 94.7 %
3 1 1.3 %
Total 75 100 %
*FREQUENCY means number patients
FIGURE - 5.3.2
Showing Varicosity Scores Distribution
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EDEMA
TABLE - 5.2.3
Edema score Frequency Percentage
Nil 8 10.8 %
2 61 81.3 %
3 4 5.3 %
4 1 1.3 %
5 1 1.3 %
Total 75 100 %
*FREQUENCY means number patients
FIGURE - 5.3.3
Showing  Edema  Scores Distribution
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SKIN CHANGES
TABLE - 5.2.4
Skin changes score Frequency Percentage
Nil 21 28.0 %
1 2 2.7 %
3 45 60.0 %
4 5 6.6 %
5 2 2.7 %
Total 75 100 %
*FREQUENCY means number patients
FIGURE - 5.3.4
Showing Skin Changes Scores Distribution
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ULCERS
TABLE - 5.2.4
Ulcers score Frequency Percentage
Nil 48 64.0 %
3 21 28.0 %
4 6 8.0 %
Total 75 100 %
*FREQUENCY means number patients
FIGURE - 5.3.5
Showing Ulcers Scores Distribution
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In the studied population more than 50(66.67%) patients were
under the category of moderate in all the clinical features including  pain,
varicose vein, edema, skin changes, ulcer.
DESCRIPTIVE STATISTICS
TABLE - 5.2.6
N Minimum Maximum Mean Std. Deviation
Age 75 24 75 44.01 12.967
Pain 75 1 3 1.63 .540
Varicosity 75 1 3 1.97 .231
Edema 75 0 5 1.91 .808
Skin changes 75 0 5 2.23 1.494
Ulcers 75 0 4 1.16 1.577
VCSS 75 3 18 8.89 3.237
VDS 75 2 3 2.05 .226
VRS 75 1 3 2.75 .468
Valid n (listwise) 75
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CATEGORY UNDER CLINICAL AND IMAGING SCORES
CATEGORY OF PATIENTS ACCORDING TO VCSS
TABLE - 5.3.1
VCSS Category Frequency Percentage
Mild 50 66.7 %
Moderate 25 33.3 %
Severe 0 0.0 %
Total 75 100 %
*FREQUENCY means number patients
Among 75 studied population according to VCSS 50 patients
(66.7%) belong to mild and 25 patients (33.3%) were of moderate
category. No patients under  severe category.
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FIGURE - 5.4.1
Showing Category of Patient according to VCSS
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CATEGORY OF PATIENTS ACCORDING TO VDS
TABLE - 5.3.2
VDS Category Frequency Percentage
0 0 0.0 %
1 0 0.0 %
2 71 94.7 %
3 4 5.3 %
Total 75 100 %
Among the 75 patients according to VDS (venous disability score)
71 patients (94.7 %) belong to the category of grade 2. Only 4 (5.3%)
patients belong to grade 3.  No patient under grade 1.
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FIGURE - 5.4.2
Showing Category of Patient according to VDS
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CATEGORY OF PATIENTS ACCORDING TO VRS
TABLE - 5.3.3
VRS Category Frequency Percentage
Mild 1 1.3 %
Moderate 17 22.7 %
Severe 57 76.0 %
Total 75 100 %
*FREQUENCY  means number of patients
Among 75 patients 57(76.0%)  belong to severe category
(grade 3 venous reflux) and 17 (22.7%) patients moderate (grade
2 venous reflux). 1(1.3%) patient with  mild reflux.
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FIGURE - 5.4.3
Showing Category of Patient according to VRS
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CATEGORY OF TABLES SHOWING GENDER AND VENOUS
REFLUX
Age category Mild Moderate Severe Total
Male 1 (1.4%) 13 (18.6%) 56(80.0%) 70 (100%)
Female 0 (0.0%) 4 (80.0%) 1 (20.0%) 5 (100%)
Total 1 (1.3%) 17 (22.7%) 57(76.0%) 75 (100%)
Chi2 – 10.051   df -2    p-Value – 0.007 (Statistically Significant)
FIGURE - 5.4.4
Showing Gender and Reflux according to VRS category
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CATEGORY OF TABLES SHOWING THE CORRELATION
BETWEEN VCSS, VDS, VRS   WITH AGE, SEX, SIDE
AGE.CAT Vs VCSS.CAT
VCSS.CAT
TotalMILD MODERATE
AGE
CAT
> 60 YEARS Count 5 2 7
% within
AGE.CAT
71.4% 28.6% 100.0%
% within
VCSS.CAT
10.0% 8.0% 9.3%
41 - 60 YEARS Count 19 15 34
% within
AGE.CAT
55.9% 44.1% 100.0%
% within
VCSS.CAT
38.0% 60.0% 45.3%
UPTO 40
YEARS
Count 26 8 34
% within
AGE.CAT
76.5% 23.5% 100.0%
% within
VCSS.CAT
52.0% 32.0% 45.3%
Total Count 50 25 75
% within
AGE.CAT
66.7% 33.3% 100.0%
% within
VCSS.CAT
100.0% 100.0% 100.0%
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Chi-Square Tests
Value df Asymp. Sig. (2-sided)
Pearson Chi-Square 3.321a 2 .190
Likelihood Ratio 3.339 2 .188
N of Valid Cases 75
AGE.CAT Vs VDS.CAT
VDS.CAT
Total2 3
AGE
CAT
> 60 YEARS Count 6 1 7
% within
AGE.CAT
85.7% 14.3% 100.0%
% within
VDS.CAT
8.5% 25.0% 9.3%
41 - 60 YEARS Count 32 2 34
% within
AGE.CAT
94.1% 5.9% 100.0%
% within
VDS.CAT
45.1% 50.0% 45.3%
UPTO 40
YEARS
Count 33 1 34
% within
AGE.CAT
97.1% 2.9% 100.0%
% within
VDS.CAT
46.5% 25.0% 45.3%
Total Count 71 4 75
% within
AGE.CAT
94.7% 5.3% 100.0%
% within
VDS.CAT
100.0% 100.0% 100.0%
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Chi-Square Tests
Value df Asymp. Sig. (2-sided)
Pearson Chi-
Square
1.517a 2 .468
Likelihood Ratio 1.255 2 .534
N of Valid Cases 75
AGE.CAT Vs VRS.CAT
VRS.CAT
TotalMILD MODERATE SEVERE
AGE
CAT
> 60
YEARS
Count 0 4 3 7
% within
AGE.CAT
.0% 57.1% 42.9% 100.0%
% within
VRS.CAT
.0% 23.5% 5.3% 9.3%
41 - 60
YEARS
Count 0 7 27 34
% within
AGE.CAT
.0% 20.6% 79.4% 100.0%
% within
VRS.CAT
.0% 41.2% 47.4% 45.3%
UPTO 40
YEARS
Count 1 6 27 34
% within
AGE.CAT
2.9% 17.6% 79.4% 100.0%
% within
VRS.CAT
100.0% 35.3% 47.4% 45.3%
Total Count 1 17 57 75
% within
AGE.CAT
1.3% 22.7% 76.0% 100.0%
% within
VRS.CAT
100.0% 100.0% 100.0% 100.0%
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Chi-Square Tests
Value df
Asymp. Sig.
(2-sided)
Pearson Chi-
Square
6.435a 4 .169
Likelihood Ratio 5.935 4 .204
N of Valid Cases 75
SEX CAT. Vs VCSS CAT.
VCSS.CAT
TotalMILD MODERATE
SEX FEMALE Count 4 1 5
% within SEX 80.0% 20.0% 100.0%
% within VCSS.CAT 8.0% 4.0% 6.7%
MALE Count 46 24 70
% within SEX 65.7% 34.3% 100.0%
% within VCSS.CAT 92.0% 96.0% 93.3%
Total Count 50 25 75
% within SEX 66.7% 33.3% 100.0%
% within VCSS.CAT 100.0% 100.0% 100.0%
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Chi-Square Tests
Value df
Asymp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
Pearson Chi-
Square
.429a 1 .513
Continuity
Correctionb
.027 1 .870
Likelihood Ratio .465 1 .495
Fisher's Exact
Test
.659 .456
N of Valid Cases 75
Risk Estimate
Value
95% Confidence Interval
Lower Upper
Odds Ratio for SEX
(FEMALE / MALE)
2.087 .221 19.725
For cohort
VCSS.CAT = MILD
1.217 .761 1.947
For cohort
VCSS.CAT =
MODERATE
.583 .098 3.469
N of Valid Cases 75
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SEX  Vs  VDS.CAT
VDS.CAT
Total2 3
SEX FEMALE Count 5 0 5
% within SEX 100.0% .0% 100.0%
% within VDS.CAT 7.0% .0% 6.7%
MALE Count 66 4 70
% within SEX 94.3% 5.7% 100.0%
% within VDS.CAT 93.0% 100.0% 93.3%
Total Count 71 4 75
% within SEX 94.7% 5.3% 100.0%
% within VDS.CAT 100.0% 100.0% 100.0%
Chi-Square Tests
Value df Asymp. Sig.(2-sided)
Exact Sig.  (2-
sided)
Exact Sig.
(1-sided)
Pearson Chi-Square .302a 1 .583
Continuity
Correctionb
.000 1 1.000
Likelihood Ratio .568 1 .451
Fisher's Exact Test 1.000 .754
N of Valid Cases 75
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Risk Estimate
Value
95% Confidence
Interval
Lower Upper
For cohort
VDS.CAT = 2
1.061 1.001 1.124
N of Valid Cases 75
TABLES 5.4 CATEGORY OF CHARTS AND TABLES SHOWING
CORRELATION BETWEEN CLINICAL AND IMAGING
SCORES
CORRELATION BETWEEN VCSS AND VRS:
TABLES - 5.4.1
VCSS and
VRS
Pearson correlation
coefficient
p-Value Sig
N=75 0.285 0.013 Significant*
In the 75 patients there is a significant correlation between VCSS
and VRS with a significant p value of 0.013.
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FIGURE - 6.4.1
Scatter Diagram showing Correlation between VCSS and VRS
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CORRELATION BETWEEN VDS AND VRS
TABLE - 5.4.2
VDS and VRS
Pearson
Correlation
Coefficient
p-Value Sig
N=75 0.129 0.268 NOT
SIGNIFICANT
In the studied 75 patients there was no significant correlation
between  VRS and VDS with insignificant p value 0.268.
FIGURE - 6.4.2
Scatter Diagram showing Correlation between VDS and VRS
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CORRELATION BETWEEN VCSS AND VDS
TABLES - 5.4.3
VCSS and
VDS
Pearson
correlation
coefficient
p-Value Sig
N=75 0.266 0.021 SIGNIFICANT*
From the above analysis there is a significant correlation between
VCSS and VRS with the significant p value 0.021.
FIGURE - 6.4.3
Scatter Diagram showing Correlation between VCSS and VDS
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CATEGORY OF CROSS
TABLES - 5.5
VCSS.CAT Vs VRS.CAT Cross tabulation
VRS.CAT
TotalMILD MODERATE SEVERE
VCSS.
CAT
MILD Count 0 15 35 50
% within
VCSS.CAT
.0% 30.0% 70.0% 100.0%
% within
VRS.CAT
.0% 88.2% 61.4% 66.7%
MODERATE Count 1 2 22 25
% within
VCSS.CAT
4.0% 8.0% 88.0% 100.0%
% within
VRS.CAT
100.0% 11.8% 38.6% 33.3%
Total Count 1 17 57 75
% within
VCSS.CAT
1.3% 22.7% 76.0% 100.0%
% within
VRS.CAT
100.0% 100.0% 100.0% 100.0%
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VDS.CAT VS VRS.CAT Cross tabulation
VRS.CAT
TotalMILD MODERATE SEVERE
VDS.CAT 2 Count 1 17 53 71
% within
VDS.CAT
1.4% 23.9% 74.6% 100.0%
% within
VRS.CAT
100.0% 100.0% 93.0% 94.7%
3 Count 0 0 4 4
% within
VDS.CAT
.0% .0% 100.0% 100.0%
% within
VRS.CAT
.0% .0% 7.0% 5.3%
Total Count 1 17 57 75
% within
VDS.CAT
1.3% 22.7% 76.0% 100.0%
% within
VRS.CAT
100.0% 100.0% 100.0% 100.0%
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 VCSS.CAT Vs  VDS.CAT Cross tabulation
VDS.CAT
Total2 3
VCSS.CAT MILD Count 49 1 50
% within
VCSS.CAT
98.0% 2.0% 100.0%
% within
VDS.CAT
69.0% 25.0% 66.7%
MODERAT
E
Count 22 3 25
% within
VCSS.CAT
88.0% 12.0% 100.0%
% within
VDS.CAT
31.0% 75.0% 33.3%
Total Count 71 4 75
% within
VCSS.CAT
94.7% 5.3% 100.0%
% within
VDS.CAT
100.0% 100.0% 100.0%
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SEX * VCSS.CAT
Crosstab
VCSS.CAT
TotalMILD MODERATE
SEX FEMALE Count 4 1 5
% within SEX 80.0% 20.0% 100.0%
% within
VCSS.CAT
8.0% 4.0% 6.7%
MALE Count 46 24 70
% within SEX 65.7% 34.3% 100.0%
% within
VCSS.CAT
92.0% 96.0% 93.3%
Total Count 50 25 75
% within SEX 66.7% 33.3% 100.0%
% within
VCSS.CAT
100.0% 100.0% 100.0%
Chi-Square Tests
Value df
Asymp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig. (1-
sided)
Pearson Chi-Square .429a 1 .513
Continuity
Correctionb
.027 1 .870
Likelihood Ratio .465 1 .495
Fisher's Exact Test .659 .456
N of Valid Cases 75
a. 2 cells (50.0%) have expected count less than 5. The minimum expected
count is 1.67.
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Chi-Square Tests
Value df
Asymp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig. (1-
sided)
Pearson Chi-Square .429a 1 .513
Continuity
Correctionb
.027 1 .870
Likelihood Ratio .465 1 .495
Fisher's Exact Test .659 .456
N of Valid Cases 75
a. 2 cells (50.0%) have expected count less than 5. The minimum expected
count is 1.67.
b. Computed only for a 2x2 table
Risk Estimate
Value
95% Confidence Interval
Lower Upper
Odds Ratio for SEX
(FEMALE / MALE)
2.087 .221 19.725
For cohort VCSS.CAT
= MILD
1.217 .761 1.947
For cohort VCSS.CAT
= MODERATE
.583 .098 3.469
N of Valid Cases 75
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SEX * VDS.CAT
Crosstab
VDS.CAT
Total2 3
SEX FEMALE Count 5 0 5
% within SEX 100.0% .0% 100.0%
% within
VDS.CAT
7.0% .0% 6.7%
MALE Count 66 4 70
% within SEX 94.3% 5.7% 100.0%
% within
VDS.CAT
93.0% 100.0% 93.3%
Total Count 71 4 75
% within SEX 94.7% 5.3% 100.0%
% within
VDS.CAT
100.0% 100.0% 100.0%
Chi-Square Tests
Value df
Asymp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
Pearson Chi-Square .302a 1 .583
Continuity
Correctionb
.000 1 1.000
Likelihood Ratio .568 1 .451
Fisher's Exact Test 1.000 .754
N of Valid Cases 75
a. 3 cells (75.0%) have expected count less than 5. The minimum expected count is
.27.
b. Computed only for a 2x2 table
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Risk Estimate
Value
95% Confidence Interval
Lower Upper
For cohort
VDS.CAT = 2
1.061 1.001 1.124
N of Valid Cases 75
SEX * VRS.CAT
Crosstab
VRS.CAT
TotalMild Moderate Severe
SEX FEMALE Count 0 4 1 5
% within SEX .0% 80.0% 20.0% 100.0%
% within
VRS.CAT
.0% 23.5% 1.8% 6.7%
MALE Count 1 13 56 70
% within SEX 1.4% 18.6% 80.0% 100.0%
% within
VRS.CAT
100.0% 76.5% 98.2% 93.3%
Total Count 1 17 57 75
% within SEX 1.3% 22.7% 76.0% 100.0%
% within
VRS.CAT
100.0% 100.0% 100.0% 100.0%
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Chi-Square Tests
Value df Asymp. Sig. (2-sided)
Pearson Chi-
Square
10.051a 2 .007
Likelihood Ratio 8.121 2 .017
N of Valid Cases 75
a. 4 cells (66.7%) have expected count less than 5. The minimum expected
count is .07.
Risk Estimate
Value
Odds Ratio for SEX
(FEMALE / MALE)
a
a. Risk Estimate statistics cannot be computed. They are only
computed for a 2*2 table without empty cells.
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SIDE * VCSS.CAT
Crosstab
VCSS.CAT
TotalMILD MODERATE
SIDE LEFT Count 22 13 35
% within SIDE 62.9% 37.1% 100.0%
% within
VCSS.CAT
44.0% 52.0% 46.7%
RIGHT Count 28 12 40
% within SIDE 70.0% 30.0% 100.0%
% within
VCSS.CAT
56.0% 48.0% 53.3%
Total Count 50 25 75
% within SIDE 66.7% 33.3% 100.0%
% within
VCSS.CAT
100.0% 100.0% 100.0%
Chi-Square Tests
Value df
Asymp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig. (1-
sided)
Pearson Chi-Square .429a 1 .513
Continuity
Correctionb
.167 1 .682
Likelihood Ratio .428 1 .513
Fisher's Exact Test .625 .341
N of Valid Cases 75
a. 0 cells (.0%) have expected count less than 5. The minimum expected count is
11.67.
b. Computed only for a 2x2 table
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Risk Estimate
Value
95% Confidence Interval
Lower Upper
Odds Ratio for SIDE
(LEFT / RIGHT)
.725 .277 1.900
For cohort VCSS.CAT
= MILD
.898 .648 1.244
For cohort VCSS.CAT
= MODERATE
1.238 .653 2.348
N of Valid Cases 75
SIDE * VDS.CAT
Crosstab
VDS.CAT
Total2 3
SIDE LEFT Count 34 1 35
% within SIDE 97.1% 2.9% 100.0%
% within
VDS.CAT
47.9% 25.0% 46.7%
RIGHT Count 37 3 40
% within SIDE 92.5% 7.5% 100.0%
% within
VDS.CAT
52.1% 75.0% 53.3%
Total Count 71 4 75
% within SIDE 94.7% 5.3% 100.0%
% within
VDS.CAT
100.0% 100.0% 100.0%
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Chi-Square Tests
Value df
Asymp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
Pearson Chi-Square .797a 1 .372
Continuity
Correctionb
.143 1 .706
Likelihood Ratio .840 1 .359
Fisher's Exact Test .618 .360
N of Valid Cases 75
a. 2 cells (50.0%) have expected count less than 5. The minimum expected count is
1.87.
b. Computed only for a 2x2 table
Risk Estimate
Value
95% Confidence
Interval
Lower Upper
Odds Ratio for SIDE
(LEFT / RIGHT)
2.757 .273 27.789
For cohort VDS.CAT
= 2
1.050 .946 1.166
For cohort VDS.CAT
= 3
.381 .041 3.498
N of Valid Cases 75
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SIDE * VRS.CAT
Crosstab
VRS.CAT
TotalMILD MODERATE SEVERE
SIDE LEFT Count 0 10 25 35
% within SIDE .0% 28.6% 71.4% 100.0%
% within
VRS.CAT
.0% 58.8% 43.9% 46.7%
RIGHT Count 1 7 32 40
% within SIDE 2.5% 17.5% 80.0% 100.0%
% within
VRS.CAT
100.0% 41.2% 56.1% 53.3%
Total Count 1 17 57 75
% within SIDE 1.3% 22.7% 76.0% 100.0%
% within
VRS.CAT
100.0% 100.0% 100.0% 100.0%
Chi-Square Tests
Value df
Asymp. Sig. (2-
sided)
Pearson Chi-
Square
2.065a 2 .356
Likelihood Ratio 2.447 2 .294
N of Valid Cases 75
a. 2 cells (33.3%) have expected count less than 5. The
minimum expected count is .47.
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DISCUSSION
This study was designed to assess the correlation between
VENOUS CLINICAL SEVERITY SCORE (VCSS), VENOUS
DISABILITY SCORE (VDS) AND VENOUS REFLUX
GRADING(VRS) BY VENOUS DOPPLER in Varicose veins of lower
limbs. Seventy five patients between 24 to 75yrs were recruited in this
study which was conducted over a period of 18 months. A detailed
history and clinical examination along with Doppler imaging was done.
The information thus collected was documented in a pre structured
proforma.
Among the 75 patients 70(93.3 %) were males and 5(6.7%)
females. In both the sexes right lower limb was found to be
predominantly affected.
On analyzing the Venous clinical severity score(VCSS)  of the75
patients, a minimum pain score of1 was seen in 40.0% of the cases under
study and a maximum of 3 in 2.7% (mean 1.63 ± 0.540). Four percent of
the cases had a varicosity score of 1 and 1.3% had a score of 3 (mean
1.97  ±  0.231).  There  was  no  edema  in  10.8%   of  the  cases  whereas  a
maximum score of 5 was seen in 1.3% (mean  1.91 ± 0.808). Twenty
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eight percent of the cases had no skin changes whereas 2.7 % cases had a
maximum score of 5 (mean 2.23 ± 1.494). sixty four percent of the
patients did not have any ulcers and 8% of them had a  maximum score of
4 (mean 1.16 ± 1.577). On categorizing our patients as per the VCSS
system, we found that 66.7% (n=50) fell into mild and 33.3% (n=25) into
moderate category, whereas none came under the severe group. Hence as
per VCSS 66.7% cases had mild disease.
On analyzing the Venous disability  score (VDS) of the75 patients,
it was found that majority of them had Grade II disability (n=71) (94.7%),
only 5.3% (n=4) of them had Grade III disability and none had grade I
VDS. Hence as per VDS system 94.7% (n=71) of the patients had grade
II disability.
On analyzing the Venous reflux score grades among the 75
patients, a significant proportion of them (n=57, 76%) had grade 3 reflux
and grade 1 and 2 reflux was seen in only 1.3% (n=1) and 22.7% (n=17),
respectively. Hence in our study 76 .0%(n=57) patients had severe grade
of venous reflux (VRS).
After analyzing the results of individual scoring system, it was
looked for correlation between each of the scoring systems and found that
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there was a statistically significant correlation between VCSS and VRS
(N=75, Pearson correlation coefficient =0.285, P value =0.013). There
was no correlation between VDS and VRS (Pearson correlation
coefficient =0.129, P value =0.268). It was also found that the clinical
features assessed as per VCSS correlated well with the disability caused
by varicose veins in lower limbs, assessed using the VDS. This
observation was statistically significant (Pearson correlation coefficient
=0.266, P value- 0.021).
In   2000    Havoc   et  al.23 Studied the relationship between lower
limb venous symptoms  with  the  venous  reflux by duplex ultrasound in
1900 patients and concluded   that the presence of  venous reflux on
duplex ultrasound scanning has relationship with  few symptoms of
lower extremity venous disease.(p value <0.07).
Passman  et al.24  found  global application of VCSS in measuring
the varicose vein related risk and changes with the treatment in 45
patients. Along with VCSS, he applied  CEAP and CVIQ (chronic venous
insufficiency affecting quality of life).
 Vasquez et al. 27done a study to assess  the quality of life changes
in varicose vein treatment in 499 patients by venous clinical severity
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score and found to be  useful (p value ;0.002) to measure the changes in
the varicose  vein treatment.
Stavros et al. 31 validated  the three components in the new scoring
system i.e  VCSS,  VDS and  VSDS which   had  a   good  correlation  with
anatomic extent of the lower limb venous disease. He advised the new
scoring systems to be  included in clinical examination for  measuring
the outcome of  the varicose vein surgery. (n = 45 patients, p value :
0.001(VCSS), p value :0.002 (VDS)
Wang  J  et  al.32 done  a  study  at   New York   as  to   how well  the
VCSS  is helpful to assess the efficacy of varicose vein treatment by
radiofrequency wave ablation and  concluded that   VCSS  was a  single
scoring system  helpful in assessing the efficacy  and  reasons for failure
of treatment. (n= 1460 patients, p value :0.025).
Edinburgh vein study34 from Scotland by vascular surgery
department in 2002 showed a  strong correlation between  lower limb
clinical features and  venous reflux by Doppler ultrasound scanning.
(n=466 patients, p value : 0.012).
Nicholls et al.36 studied to identify the usefulness of VCSS system
in varicose vein risk assessment and to evaluate the changes after
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varicose vein treatment in 68 patients. The study concluded that VCSS
was  useful(p value :0.015) in the above measurement.
In  2006  Miami  et  al.37 done a study include 2894 patients to
compare the parameters between VCSS and CEAP in varicose vein
management and concluded that the VCSS was a very good system(p
value:0.001) in diagnosis and follow up of chronic venous insufficiency
of lower limbs.
Padberg et al. 38 in 2000 done a study in 191 patients  to find out
which one was better in varicose vein  clinical features assessment  and
measure the changes after treatment for varicose vein among CEAP and
VCSS and  found VCSS would be the ideal tool(p value : 0.001) to
measure the outcome and risk assessment in varicose vein  compared to
CEAP which already existed  for many years.
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SUMMARY
The study was aimed at studying the correlation between
VENOUS CLINICAL SEVERITY SCORE (VCSS), VENOUS
DISABILITY SCORE (VDS) AND VENOUS REFLUX GRADING
BY VENOUS DOPPLER in Varicose veins of lower limbs.
This study was conducted in the Department of General surgery,
ESI-PGIMSR, over a period of  18months.  The study group consisted of
75 patients between 24 to 75yrs (mean 44.41 ± 12.967), inclusive of both
males (n=70) and females (n=5). They were assessed for severity of
varicose veins by documenting a detailed history, clinical examination
findings and imaging studies on a pre structured  proforma.
It was found that majority of the patients were ? 60yrs and the right
lower limb was predominantly affected in both sexes.
Using the VCSS system, 66.7% (n=50) cases had mild disease,
33.3% (n=25) cases had moderate disease and none had severe disease.
In  the  present  study,  as  per  the  VDS  system,  majority  of  the
patients (n=71, 94.7%) had grade II disability. And 76% (n=57) of the
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patients had severe grade of venous reflux i.e. venous reflux duration
>1second.
A statistically significant correlation was found between clinical
manifestations of varicose veins and the degree of reflux in the veins,
assessed using the VCSS and VRS system, respectively.
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CONCLUSION
Seventy five cases of primary varicose veins of the lower limb
have been studied in a prospective manner strictly abiding to the
objectives, inclusion and exclusion criteria. An analysis of the data has
enabled us to arrive at the following conclusions.
1. Varicose vein clinical features including pain, varicosity,
oedema, skin changes  and  ulcer   significantly correlates with
the venous reflux at SFJ.
2. Varicose vein develops as a result of venous reflux and the
same is responsible for the clinical features and its
complications.  Intervention in Grade II and III venous reflux in
asymptomatic patients can be the ideal treatment to prevent
complications.
3. The  VCSS  and  VRS   have  a  significant  role  as  compared  to
VDS in planning the better modality of  treatment to prevent
disease related morbidity and its complications.
4. VCSS- venous clinical severity score   is easily applicable to  all
patients as a bed side score compare to traditional scoring
systems.
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